an experimental experience

5/25/23 at 4:57pm

Organization

Author

Robert Barrie

37 words

Comments

The affordable NmCV-5 vaccine is a step up from existing options that could contribute to WHO’s goal to defeat the epidemic by 2030.

You are the first to view

http://www.pharmaceutical-technology.com/news/meningitis-vaccine-comes-to-the-forefront-with-impressive-study-results/

Create an account or login to join the discussion